IRulya Therapeutics QNCX
NASDAQ QNCX
$34.68 -5.59 (-13.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Profit After Tax (2018 - 2026)

Updated

IRulya Therapeutics' Profit After Tax was -$75.51 million in Q2 2026, compared with -$16.05 million a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) Profit After Tax (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, IRulya Therapeutics' Profit After Tax was -$92.5 million through Jun 30, 2026; for FY2025, it was -$83.98 million.

  • In earlier years, Profit After Tax was -$56.83 million in FY2024, -$31.39 million in FY2023 and -$51.66 million in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Profit After Tax in data going back to Q1 2018.
  • Per Business Quant data, QNCX's Profit After Tax in the three quarters before Q2 2026 was $35.91 million (Q1 2026), -$39.46 million (Q4 2025) and -$13.44 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -75.51 Mn
Mar 31, 2026 35.91 Mn
Dec 31, 2025 -39.46 Mn
Sep 30, 2025 -13.44 Mn
Jun 30, 2025 -16.05 Mn
Mar 31, 2025 -15.03 Mn
Dec 31, 2024 -12.46 Mn
Sep 30, 2024 -5.49 Mn
Jun 30, 2024 -27.73 Mn
Mar 31, 2024 -11.15 Mn
Dec 31, 2023 -8.89 Mn
Sep 30, 2023 -5.35 Mn
Jun 30, 2023 -4.89 Mn
Mar 31, 2023 -12.25 Mn
Dec 31, 2022 -5.53 Mn
Sep 30, 2022 -7.92 Mn
Jun 30, 2022 -16.56 Mn
Mar 31, 2022 -21.64 Mn
Dec 31, 2021 66.55 Mn
Sep 30, 2021 -21.71 Mn
API Access

Quince Therapeutics, Inc. Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=QNCX&period=max&api_key=YOUR_API_KEY